| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/14/2005 | WO2005063810A1 Isolated cytotoxic factor associated with multiple sclerosis and method of detecting said cytotoxic factor |
| 07/14/2005 | WO2005063805A1 Antibodies against the amino terminus region of circumsporozoite protein prevent the onset of malaria infection |
| 07/14/2005 | WO2005063801A2 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof |
| 07/14/2005 | WO2005063335A2 MONOCLONAL DES-LYS58-β2-MICROGLOBULIN ANTIBODIES FOR MEASUREMENT AND MANAGEMENT OF HEMODIALYSIS COMPLICATIONS |
| 07/14/2005 | WO2005063299A2 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 07/14/2005 | WO2005063292A2 Heh4 molecules and uses thereof |
| 07/14/2005 | WO2005063290A2 Use of il-18 binding protein in inflammations |
| 07/14/2005 | WO2005063289A1 Cd40 antibody formulation and methods |
| 07/14/2005 | WO2005063286A1 Antibodies for oncogenic strains of hpv and methods of their use |
| 07/14/2005 | WO2005063282A1 Anti-retroviral agents, compositions, methods and uses |
| 07/14/2005 | WO2005062979A2 Immunoassays, haptens, immunogens and antibodies for anti-hiv therapeutics |
| 07/14/2005 | WO2005062977A2 Prostate cancer specific internalizing human antibodies |
| 07/14/2005 | WO2005062972A2 Treatment of cancer with novel anti-il 13 monoclonal antibodies |
| 07/14/2005 | WO2005062967A2 Novel anti-il 13 antibodies and uses thereof |
| 07/14/2005 | WO2005062955A2 Agonist anti-trkc antibodies and methods using same |
| 07/14/2005 | WO2005062929A2 Use of fc receptor polymorphisms as diagnostics for treatment strategies for immune-response disorders |
| 07/14/2005 | WO2005062916A2 Methods for generating multimeric molecules |
| 07/14/2005 | WO2005062893A2 Anti-cd52 antibody treatment for diabetes |
| 07/14/2005 | WO2005062871A2 Tat linear epitope peptides and conjugates thereof for use in therapeutic compositions and assays |
| 07/14/2005 | WO2005033274A3 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom |
| 07/14/2005 | WO2005026210A3 Therapeutic binding molecules |
| 07/14/2005 | WO2005012481A3 Non-immunoglobulin binding polypeptides |
| 07/14/2005 | WO2005000871A3 Peptides antagonistic to an anti-angiogenic antibody and uses therefor |
| 07/14/2005 | WO2004108765A3 Extracellular aspergillus polypeptides |
| 07/14/2005 | WO2004098535A3 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 07/14/2005 | WO2004091375A3 Epha2 and non-neoplastic hyperproliferative cell disorders |
| 07/14/2005 | WO2004087042A3 Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins |
| 07/14/2005 | WO2004085475A3 Anti-il-20 antibodies and binding partners and methods of using in inflammation |
| 07/14/2005 | WO2004017923A3 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
| 07/14/2005 | WO2003068916A3 Methods and apparatus for whole cell panning |
| 07/14/2005 | WO2003029424A3 Novel proteins and nucleic acids encoding same |
| 07/14/2005 | US20050155103 Transgenic plants expressing lepidopteran-active delta-endotoxins |
| 07/14/2005 | US20050155094 Expression vector comprising nucleotide sequences coding human recombination activating protein (RAG-1) gene for use as tool in generating immunodeficient pigs; animal models and immunotherapy |
| 07/14/2005 | US20050155092 Mutant muscle protein nucleotide sequences for use in generating animal models for diagnosis and treatment of cardiovascular disorders |
| 07/14/2005 | US20050155090 Recombinant monoclonal antibody for use in prevention and treatment of cell proliferative disorders; antiproliferative agents; immunotherapy |
| 07/14/2005 | US20050155089 Transport protein for use in identifying modulators for prevention and treatment of inflammation, cardiovascular, neurological, reproductive and developmental disorders |
| 07/14/2005 | US20050154193 Immunoglobulin for use in diagnosis, prevention and treatment of infection, neurodegenerative, inflammatory and autoimmune disorders; immunotherapy |
| 07/14/2005 | US20050154192 Anti-il13 receptor alpha1 neutralizing antibody |
| 07/14/2005 | US20050153917 Gene overexpression/underexpression; antibodies; drug screening; kits |
| 07/14/2005 | US20050153910 Antibody and inhibitor and transformation method and transformation kit using the same |
| 07/14/2005 | US20050153890 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 07/14/2005 | US20050153888 oligopeptides capable of stimulating the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM), used for treatment of normal, degenerated and damaged NCAM presenting cells |
| 07/14/2005 | US20050153878 Fgfr agonists |
| 07/14/2005 | US20050153447 Closed culture vessel comprising inlet and outlet filters for use in propagation of lymphocytes; bioreactors |
| 07/14/2005 | US20050153439 Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs |
| 07/14/2005 | US20050153414 Regulator of G-protein signaling (RGS) polypeptide for use as tools in identifying modulators of cell signaling; antitumor agents; mimetics |
| 07/14/2005 | US20050153396 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/14/2005 | US20050153395 Unique integrin binding site in connective tissue growth factor (CTGF) |
| 07/14/2005 | US20050153394 Targeting construct for use as tool in enhanced transfer gene sequences into cells; bioreactors; improving exogenous gene expression |
| 07/14/2005 | US20050153392 Transgenesis with humanized immunoglobulin loci |
| 07/14/2005 | US20050153381 Monoclonal antibody for use in diagnosing oxidative phosphorylation system (OXPHOS) disorders; immunodiagnostics; focused proteomic analysis of mitochondrial proteins |
| 07/14/2005 | US20050153378 Anti-dioxins monoclonal antibody suitable for assaying dioxins in environment and hybridoma producing the same |
| 07/14/2005 | US20050153375 CEA/NCA-based differentiation cancer therapy |
| 07/14/2005 | US20050153374 Peptides and polypeptides derived from the submaxillary gland of the rat, corresponding polyclonal and monoclonal antibodies, corresponding hybridomas and uses of these products for diagnosis, for detection or therapeutic purposes |
| 07/14/2005 | US20050153373 Isolated from Bacillus substilis; multimeric polypeptide antigens; antibodies; solid phase synthesis; reverse transcription; kits; immunohistochemistry |
| 07/14/2005 | US20050153369 Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX |
| 07/14/2005 | US20050153352 Using oncogenic protein (MG20) as tool in identifying modulators for diagnosis prevention and treatment of cell proliferative disorders |
| 07/14/2005 | US20050153348 Using membrane protein expression pattern as diagnostic and prognostic tool in detection of breast, colon and lung tissue cell proliferative disorders |
| 07/14/2005 | US20050153335 Expression vector comprising nucleotide sequences coding membrane protein for use in identifying modulator for prevention and treatmment of cell proliferative, inflammatory and nervous system disorders |
| 07/14/2005 | US20050153334 Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides |
| 07/14/2005 | US20050153332 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 07/14/2005 | US20050153329 Method for determining immune system affecting compounds |
| 07/14/2005 | US20050153315 Nucleotide sequences coding polypeptide comprising methylarginase activities for use in identifying modulator for prevention and treatment of ischemia-reperfusion injuries, cancer, hypotension, multi-organ failure, arthritis, skin, inflammatory, cardiac and/or migraine disorders |
| 07/14/2005 | US20050153057 Lipopolysaccharide for influenza vaccines and respiratory system disorders |
| 07/14/2005 | US20050152927 Allergenic proteins and peptides from Japanese cedar pollen |
| 07/14/2005 | US20050152919 Measles virus antigens with a Proteosome-based adjuvant; treating or preventing a measles virus infection |
| 07/14/2005 | US20050152913 Process for preapring maytansinol |
| 07/14/2005 | US20050152912 Lymphotropic retrovirus disease treatment and diagnosis such as acquired immunodeficiency syndrome (AIDS); Specifically binds with high specificity and affinity a particular human APM:pathogen-derived antigen complex |
| 07/14/2005 | US20050152911 Norovirus monoclonal antibodies and peptides |
| 07/14/2005 | US20050152910 Immunoglobulin igg3 as a marker for protecting against infectious viral diseases, and the uses of the same |
| 07/14/2005 | US20050152909 Prostate stem cell antigen (PSCA) tumor antigen for use in diagnosis, prevention and treatment of prostate cancers |
| 07/14/2005 | US20050152908 Expressed in blood and useful in diagnosing liver cancer as well as monitoring therapeutic efficacy; polynucleotides; eg amyloid beta (A4) precursor-like protein 2 (APLP2); BCL2-related protein A1 (BCL2A1) |
| 07/14/2005 | US20050152907 Used to diagnose and treat various diseases, including human cancers associated with expression and/or over-expression of KID3 |
| 07/14/2005 | US20050152906 Specific human antibodies |
| 07/14/2005 | US20050152905 by concurrent administration of prostaglandin inhibitors, modulator of neurotransmitters, interleukin inhibitors and tumor necrosis factor -lpha (TNF-alpha) inhibitors |
| 07/14/2005 | US20050152904 Novel P-selectin glycoprotein ligand (PSGL-1) binding protein and uses therefor |
| 07/14/2005 | US20050152903 antibodies or FAB fragments that specifically binds to high mobility group box (HMGB) proteins but does not specifically bind to non-A box epitopes of HMGB; inhibiting release of proinflammatory cytokine from from a vertebrate cell treated with high mobility group protein |
| 07/14/2005 | US20050152902 administering antibodies to gamma interferon and CD20 antigens |
| 07/14/2005 | US20050152901 interferon antagonists, such as anti-type 1 interferon receptor antibody antagonists and fragments, as well as polypeptides and small molecules that inhibit the interaction of type 1 interferon with its cell-surface receptors; treatment of gastrointerstinal disorders and autoimmune diseases |
| 07/14/2005 | US20050152900 Compositions and methods for apo-b48 and apo-b100 assay |
| 07/14/2005 | US20050152899 EphA2 agonistic monoclonal antibodies and methods of use thereof |
| 07/14/2005 | US20050152898 Provides for modified forms of anti-CD52 antibodies with reduced numbers of potential T-cell epitopes that are expected to display decreased immunogenicity, for therapy of autoimmune conditions |
| 07/14/2005 | US20050152897 Methods for inducing T cell tolerance to a tissue or organ graft |
| 07/14/2005 | US20050152896 Anti-galanin antibodies and uses thereof |
| 07/14/2005 | US20050152895 comprising administering antibodies to tissue inhibitors metalloproteinases (TIMP-1), Fab fragments or TIMP-1antisense oligonucleotides, optionally mixed with carrier such as hyaluronic acid |
| 07/14/2005 | US20050152894 Antibodies with altered effector functions |
| 07/14/2005 | US20050152893 Methods and materials for the inhibition of transplant rejection |
| 07/14/2005 | US20050152892 Epitopes or mimotopes derived from the C-epsilon-3 or C-epsilon-4 domains of IgE, antagonists thereof, and their therapeutics uses |
| 07/14/2005 | US20050152878 Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases |
| 07/14/2005 | US20050152873 Containing an immunogen, a first adjuvant functioning as a directing molecule and a second adjuvant functioning as a stimulant which are chemically distinct |
| 07/14/2005 | US20050152837 Novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 07/14/2005 | US20050152836 Diagnostic markers and pharmacological targets in heart failure and related reagents and methods of use thereof |
| 07/14/2005 | CA2704300A1 Cd40 antibody formulation and methods |
| 07/14/2005 | CA2592504A1 Classification of cancer |
| 07/14/2005 | CA2552372A1 A process for preparing egg yolk antibodies |
| 07/14/2005 | CA2552155A1 Use of il-18 binding protein in inflammations |
| 07/14/2005 | CA2551920A1 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 07/14/2005 | CA2551915A1 Il-7 fusion proteins |
| 07/14/2005 | CA2551813A1 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 07/14/2005 | CA2551560A1 Antibodies for oncogenic strains of hpv and methods of their use |